Shares of Recursion Pharmaceuticals are trading higher Monday after the company reported positive data from an ongoing trial.

Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

AI can help design AI systems: automating architecture choices, discovering algorithms, and optimizing hardware ...

In 2025, Anthropic will grow from $1 billion to $9 billion in ARR (annual recurring revenue). OpenAI, meanwhile, will go from ...

Patronus AI unveiled “Generative Simulators,” adaptive “practice worlds” that replace static benchmarks with dynamic ...

Skills—a capability that allows users to teach Claude repeatable workflows—was introduced in October, and now Anthropic is ...

Wang Zhi, dean of the School of Fine Arts, explained, "Through this theme, we aim to anchor intellectual weight in an era of ...

Instead of a single, massive LLM, Nvidia's new 'orchestration' paradigm uses a small model to intelligently delegate tasks to a team of tools and specialized models.

Anthropic's chief scientist warns AI could threaten humanity as industry anxiety rises following an OpenAI researcher's exit.

As language models (LMs) improve at tasks like image generation, trivia questions, and simple math, you might think that ...

Precise underwater navigation is critical for autonomous and remotely operated deep-sea vehicles, yet variations in seawater ...